| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.3M | -4.9% | -19.2% |
| Cost of Revenue | $20.8M | +3.7% | -13.5% |
| Gross Profit | $8.5M | -20.9% | -30.3% |
| R&D Expense | $1.1M | -0.5% | +9.8% |
| SG&A Expense | $8.7M | -35.7% | -27.8% |
| Operating Income | -$3.9M | -0.8% | -359.1% |
| Pre-tax Income | -$6.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.8M | +55.3% | +12.6% |
| Accounts Receivable | $19.7M | -8.2% | -22.5% |
| Inventory | $26.1M | -7.5% | -38.4% |
| Current Assets | $69.9M | +5.6% | -19.9% |
| Total Assets | $99.6M | +0.4% | -29.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | — |
| Capital Expenditures | $158K | — | — |
| Investing Cash Flow | -$158K | — | — |
| Financing Cash Flow | $5.7M | — | — |
| Free Cash Flow | -$2.0M | — | — |
| -45.0% |
| -109.7% |
| Income Tax | -$261K | -195.3% | -2075.0% |
| Net Income | -$6.2M | -31.0% | -102.0% |
| EPS (Basic) | -$1.88 | -22.9% | -452.9% |
| EPS (Diluted) | -$1.88 | -22.9% | -452.9% |
| $68.4M |
| +2.5% |
| +64.7% |
| Long-term Debt | $36.7M | -6.0% | -5.4% |
| Total Liabilities | $90.5M | -0.9% | -14.9% |
| Stockholders' Equity | -$19.5M | +5.7% | -397.5% |